https://www.selleckchem.com/Proteasome.html
After adjustment for covariates, p-VT was associated with high favorable 30-day neurological survival rates (adjusted odds ratio [OR], 1.85; 95% confidence interval [CI], 1.30-2.64, p = 0.001), 30-day survival rates (adjusted OR, 1.41; 95% CI, 1.03-1.95, p = 0.037), and prehospital ROSC rates (adjusted OR, 1.90; 95% CI, 1.42-2.55, p 0.001). In this study, patients with p-VT as the initial documented rhythm had significantly better outcomes than those with VF. In this study, patients with p-VT as the initial documented rhythm had signific